Fig. 2.
Overall survival (OS) in patients with and without anti-thyroid antibodies (ATAs) at baseline
Solid and dashed lines indicate the OS of patients who did and did not have ATAs at baseline, respectively.
Fig. 2A: OS in patients with ≥50% PD-L1 positivity.
Fig. 2B: OS in patients with <50% PD-L1 positivity.